
Home / News
-
-
-
Arch Venture Partners, an investment company headquartered in Chicago, IL, announced on April 2, 2020 that it closed two new funds2020-04-22View More
-
-
-
-
Alnylam Pharmaceuticals, an RNA interference (RNAi) therapeutics company located in Cambridge, MA, and Blackstone Life Sciences, a private investment platform2020-04-22View More
-
-
-
-
The novel coronavirus pandemic has presented the global pharma industry with a double challenge: to develop potential treatments and preventative vaccines, and continue to meet the existing needs of healthcare providers and patients2020-04-22View More
-
-
-
-
Moderna, a clinical stage biotechnology company headquartered in Cambridge, MA, announced on April 16, 2020 that the Biomedical Advanced Research and Development Authority (BARDA)2020-04-22View More
-
-
-
-
4D pharma to Launch Phase-II Study of Biotherapeutic Product for COVID-19 Treatment2020-04-22View More
-
-
-
-
Mannitol has been shown to improve patient perceptions of tablet flavor and mouthfeel, but its use can add to tableting challenges. SPI Pharma has developed new grades of material designed to make it easier to manufacture in patient-centered formulations.2020-04-22View More
-
-
-
-
A quick look at the history of OTC dosage form development shows the importance of patient-centered innovation.2020-04-22View More
-
-
-
-
Industry opportunities are increasing for biosimilars, but companies should pay close attention to delivery device design to facilitate success.2020-04-22View More
-
-
-
-
Applied DNA Sciences said on Tuesday that it has partnered with Stony Brook University Hospital to validate the company's SARS-CoV-2 diagnostic.2020-04-22View More
-
-
-
-
Envisagenics announced Tuesday it has entered into a research program agreement with Johnson & Johnson's Lung Cancer Initiative (LCI.)2020-04-22View More
-
-
-
-
A group of life sciences and bioinformatics companies have banded together in the race to find treatments, vaccines, and a cure for COVID-19.2020-04-22View More
-
-
-
-
Austrian biopharma firm Viravaxx said on Tuesday that it is collaborating with the Medical University of Vienna to create a platform for diagnostic and vaccine research into COVID-19.2020-04-22View More
-
-
-
-
Exact Sciences reported on Tuesday after the close of the market that its preliminary first quarter revenues are expected to rise about 115 percent2020-04-22View More
-
-
-
-
South Korean molecular diagnostics firm Seegene announced after the close of the market on Tuesday that the US Food and Drug Administration has granted Emergency Use Authorization for the firm's Allplex 2019-nCoV Assay2020-04-22View More
-
-
-
-
A new study launched by scientists at Hannover Medical School (MHH) in Germany is determined to find out why patients respond differently to COVID-19.2020-04-22View More
-
-
-
-
Two months into the COVID-19 pandemic, the number of SARS-CoV-2 molecular diagnostic tests across the US remains woefully inadequate.2020-04-22View More
-
-
-
-
In the months since SARS-CoV-2 emerged and began spreading, researchers have been attempting to collect new data to understand the virus and COVID-19 disease it causes.2020-04-22View More
-
-
-
-
Genomic epidemiology papers from two independent teams are exploring potential sources of recent SARS-CoV-2 introductions to China's Guangdong province and to Connecticut, respectively2020-04-22View More
-
-
-
-
A new consortium spearheaded by the New York Genome Center aims to foster and organize genomic COVID-19 research in the New York metropolitan area.2020-04-22View More
-
-
-
-
A public-private consortium in Israel will collect samples and sequence genomes from thousands of COVID-19 patients in an effort to identify protective and risk-bearing genetic factors with the hopes of discovering new diagnostic and treatment methods.2020-04-15View More
-
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.